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1. Introduction
  Cryptococcus neoformans is a ubiquitous, yeast like fungus 
found rampantly in the soil with avian droppings. Although 
Cryptococcus most commonly involves the central nervous 
system in AIDS patients, gastrointestinal tract (GIT) can also 
be affected. As documented by Laguna et al[1], up to 90% 
of HIV-positive patients experience GI symptoms during 
the course of their disease. GI opportunistic infections 
are more commonly seen in esophagus and intestine. The 
esophageal symptoms are usually due to candidiasis, 
cytomegalovirus (CMV) or herpes while diarrhea may be 
caused by shigella, giardia, campylobacter like organisms, 
entamoeba, chlamydia, gonorrhea and syphilis[2]. However, 
Opportunistic infections are less common in the stomach. 
We report a rare case of cryptococcal gastritis with 
esophageal herpes infection, diagnosed on endoscopic 
biopsy in an AIDS patient who presented initially with 
gastric symptoms[3].
2. Case report
  A 48 year old male patient presented with history of 
odynophagia since 15 days and intractable vomiting since 3 
days. Patient was diagnosed to be human immunodeficiency 
virus (HIV) positive 1 month earlier but was not started 
on antiretroviral therapy. Clinical examination revealed 
oral candidiasis which was treated with oral fluconazole. 
Investigations revealed elevated erythrocyte sedimentation 
rate (ESR) and CD4 count of 10 cells/cumm. All other 
routine investigations were within normal limits. An upper 
GI endoscopy showed esophageal, gastric and duodenal 
erosion from which biopsies were performed. Gastric biopsy 
showed inflamed antral mucosa and crypts surrounded by 
numerous encapsulated, budding, periodic acid Sciff (PAS) 
and silver stain positive yeast forms measuring 4-15micron 
size suggestive of cryptococcus (Figure 1). Esophageal 
biopsy showed cells with intranuclear inclusions of herpes 
simplex virus(Figure 2). No cryptococci were identified in 
the esophageal biopsy.
3. Discussion
  Cryptococcus neoformans is known to cause significant 
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fatal deep mycotic infections in immunocompromised 
patients. Individuals at high risk for cryptococcosis include 
patients with immunocompromised states, hematological 
malignancies, solid organ transplants recipients, patients 
on glucocorticoid therapy and those with advanced HIV 
infection. Though cryptococcus is a common fungal 
pathogen in HIV, cryptococcal infection is usually seen at 
CD4 counts < 200 cells/cumm manifesting primarily in the 
lung, brain, eye or central nervous system (CNS) with the two 
most common manifestations being meningoencephalitis 
and pulmonary infiltrates[4,5]. Dissemination is a rare feature 
of cryptococcosis, involving many organs which may be 
clinically silent but found during autopsy[6].
Figure 1. Gastric antral mucosa and crypts showing encapsulated 
budding yeast forms (H&E 200伊). 
Figure 2. Esophageal biopsy showing intranuclear herpes simplex 
inclusions(H&E 400伊).
  Gastrointestinal and hepatobiliary disorders are 
among the most frequent complaints in patients with 
HIV disease. Review of literature identifies only few 
reports of gastrointestinal involvement in AIDS or other 
immunosupressed patients. Although the usual site of entry 
for cryptococci is inhalation, GI tract may also serve as a 
portal of entry by aspiration of contents [6,7].
  In AIDS patients, though CMV or Cryptosporidium parvum 
infections  are usually causative in   gastric ulceration and 
inflammation, other organisms like Toxoplasma gondii, 
Leishmania donovani, Mycobacterium avium-intracellulare 
complex (MAC), Treponema pallidum, Bartonella henselae, 
Bartonella quintana, and Cryptococcus neoformans, and 
phlegmonous  have also been documented[1].
  Diagnosing GI cryptococcosis can be difficult due to the 
paucity of organisms, lack of recognition of the yeasts as 
cryptococci or lack of awareness that such infection can 
occur in GI tract, leading to under reporting of these cases. 
Further, gastric mucin and cryptococcus both show positivity 
with mucin stains, making identification more difficult. Out of 
24 autopsy cases of AIDS  reviewed by Washington et al [7],only 
8 cases had evidence of gastrointestinal cryptococcosis, of 
which only 3 cases  were diagnosed antemortem.
  Though intravenous amphoterecin -B is the treatment of 
choice for disseminated and cryptococcal meningitis, no 
distinct literature is available regarding the managenment 
of gastric cryptococcosis. Owing to patient’s financial 
constraint and disinclination for management, treatment 
could not be instituted in our case.
  In conclusion, we would like to emphasize that the 
clinician must always weigh the discomfort and invasiveness 
of a procedure against the severity of the patient’s 
complaints and the likelihood of identifying a treatable 
condition. Thus, patients who are incapacitated by severe 
gastrointestinal symptoms should be evaluated more 
extensively with endoscopic or imaging studies than patients 
whose symptoms do not interfere with daily activities.
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